XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Net Unrealized Gains (losses) on Investments [Member]
Foreign Currency Translation [Member]
Nonredeemable Noncontrolling Interests [Member]
Balance at Dec. 31, 2019 $ 60,436 $ 9 $ 7 $ 61,178 $ 589 $ (4,167) $ 2,820
Balance (Adjustment to Adopt ASU 2016-13) at Dec. 31, 2019 (28)     (28)      
Balance (in shares) at Dec. 31, 2019   948          
Net earnings attributable to UnitedHealth Group common shareholders 3,382     3,382      
Net earnings attributable to nonredeemable noncontrolling interest             59
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 3,441            
Other comprehensive loss (1,782)       (283) (1,499)  
Issuances of common stock, and related tax effects (in shares)   5          
Issuances of common stock, and related tax effects 321 $ 1 320        
Share-based compensation 234   234        
Common share repurchases (in shares)   (6)          
Common share repurchases (1,691) $ 0 (510) (1,181)      
Cash dividends paid on common shares (1,024)     (1,024)      
Redeemable noncontrolling interests fair value and other adjustments (51)   (51)        
Acquisition and other adjustments of nonredeemable noncontrolling interests 50           50
Distribution to nonredeemable noncontrolling interests (43)           (43)
Balance at Mar. 31, 2020 59,863 $ 10 0 62,327 306 (5,666) 2,886
Balance (in shares) at Mar. 31, 2020   947          
Balance at Dec. 31, 2020 $ 68,328 $ 10 0 69,295 1,336 (5,150) 2,837
Balance (in shares) at Dec. 31, 2020 946 946          
Net earnings attributable to UnitedHealth Group common shareholders $ 4,862     4,862      
Net earnings attributable to nonredeemable noncontrolling interest             80
Net Earnings, Including Portion Attributable to Nonredeemable Noncontrolling Interest 4,942            
Other comprehensive loss (1,012)       (595) (417)  
Issuances of common stock, and related tax effects (in shares)   3          
Issuances of common stock, and related tax effects 256 $ 0 256        
Share-based compensation 242   242        
Common share repurchases (in shares)   (5)          
Common share repurchases (1,650) $ 0 0 (1,650)      
Cash dividends paid on common shares (1,181)     (1,181)      
Redeemable noncontrolling interests fair value and other adjustments (604)   (498) (106)      
Acquisition and other adjustments of nonredeemable noncontrolling interests 66           66
Distribution to nonredeemable noncontrolling interests (74)           (74)
Balance at Mar. 31, 2021 $ 69,313 $ 10 $ 0 $ 71,220 $ 741 $ (5,567) $ 2,909
Balance (in shares) at Mar. 31, 2021 944 944